What the Research Suggests Most of the existing evidence comes from preclinical (animal) studies
10.1016/j.crohns.2012.10.016 J
, myeloperoxidase, leukotriene B4, tromboxane B2) (44), interacts with prostaglandin-dependent pathways (45, 46), has a direct protective and proliferative effect on target cells (18, 19), and modulates the release of nitric oxide (27)
Linearity The linearity of the kit was assayed by testing samples spiked with appropriate concentration of GLP1 and their serial dilutions
doi: 10.18433/J3CC86 Summary Keywords type 2 diabetes mellitus, glucagon-like peptide-1 receptor agonists, gastrointestinal side effects, risk factors, nomogram Citation Gao R, Li Y, Li A, Zhou P, Zong H and Li Y (2024) Risk factor screening and prediction modeling of gastrointestinal adverse reactions caused by GLP-1RAs